UK Guidance On Leadless Pacemakers Is A Prelude To Requirements Under EU MDR
Executive Summary
New UK guidance on the clinical evaluation of leadless cardiac pacemakers provides useful advice on ranges of patient size for clinical studies and minimum data points.
You may also be interested in...
EU Industry Says Real Work Starts Now On Regulations
Industry recognizes considerable work has been done on cleaning up the texts of EU's future Medical Device and IVD Regulations. But it emphasized that further work is needed in the implementation phase to bring legal certainty and clarification.
Pakistan Explains Updated Risk-Based Criteria For GCP Inspections
Pakistan’s drug regulator is hoping that improved transparency on its inspection protocols will help research entities better prepare for good clinical practice inspections.
UK MHRA Inspector Highlights Mistakes Made In Decentralized Clinical Trials
Inadequate risk assessments, participant confidentiality breaches and issues with documenting and verifying clinical trial activities have emerged as recurring themes in inspections of decentralized clinical trials by the UK medicines regulator.